• Heron Therapeutics (HRTX) Momentum on Top-Line Study Results; Is Rosetta Stone (RST) a Takeover Target?

    Heron Therapeutics, Inc. (HRTX) Shares of HRTX soared to reach a record high in extended-hours trading Thursday after the company reported positive, top-line results from its recently completed Phase 3 MAGIC study. According to HRTX, its 5-HT3 receptor antagonist product candidate SUSTOL (granisetron injection, extended release), as part of a three-drug regimen, demonstrated superiority to the currently recommended standard-of-care, three-drug regimen (which uses ondansetron as 5-HT3 receptor antagonist) for delayed nausea and vomiting after administration of highly emetogenic chemotherapy agents. HRTX also said that SUSTOL-based regimen was
  • Kevin Douglas Bets on EnteroMedics (ETRM); Popeyes (PLKI) and AMERCO (UHAL) Top Estimates

    EnteroMedics Inc. (ETRM) Kevin Douglas, an active securities and commodities investor, disclosed on Wednesday in a regulatory filing ( SC 13D ) with the Securities and Exchange Commission (SEC) a 14.2% stake in ETRM (10,951,705 shares). ETRM reported last week the U.S. first ever commercial implant of its FDA-approved Maestro(R) Rechargeable System, which delivers vBloc(R) Neurometabolic Therapy that allows patients to safely lose weight by helping them feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. ETRM is a medical device company focused on the development and commercialization of its n
  • XBiotech (XBIT) Biotechnology-Cloning Anti-Ebola; RadiSys (RSYS) Inks 8-Figure Deal

    XBiotech Inc. (XBIT) Shares of XBIT surged more than 10% in after-hours trading Tuesday as the company reported that it has successfully isolated and cloned an anti-Ebola product candidate using its True Human antibody discovery platform True Human antibodies are derived directly from human donors that have natural immunity to disease. According to XBIT, the anti-Ebola product candidate that could be used to treat the disease was developed from a blood donation received earlier this year from a patient who recovered from Ebola infection. XBIT is pioneering a new era in the discovery and development of targeted antibodies based on its True H
  • Nevro (NVRO) Attracts Bay City Capital; Point72 Asset Shows Confidence In Bloomin’ Brands (BLMN)

    Nevro Corp. (NVRO) Bay City Capital LLC, a life sciences investment firm, disclosed in a regulatory filing ( Form SC 13G ) with the Securities and Exchange Commission (SEC) that it owns 2,217,214 shares of NVRO, representing an 8.9% stake in the company. The U.S. Food and Drug Administration (FDA) approved this month NVRO‘s Senza spinal cord stimulation system as an aid in the management of chronic intractable pain of the trunk and/or limbs. After the closing bell on Friday, NVRO said that the first commercial case has been performed in the United States of the Senza spinal cord stimulation system, which delivers the company’s
  • Autobytel (ABTL) Boosts Guidance Significantly, Pershing Square Capital Sees Potential In Actavis (ACT)

    Autobytel Inc. (ABTL) Shares of ABTL soared to near 52-week high in extended-hours trading Thursday as the company said that it has acquired Dealix Corporation and Autotegrity, Inc. for $25 million in an all-cash transaction and raised its business outlook for 2015. According to ABTL, the acquisition is expected to be accretive to net income in 2015 and adds approximately 600 retail new dealers and 300 retail used dealers to the company’s network, for a combined total of approximately 4,954 automotive dealers. Following the transaction, ABTL has revised its guidance for fiscal 2015 and now expects revenues to range between $128.0 mi
  • Omnicare (OCR) At All-Time High Levels On Potential Buyout, Glenview Capital Raises Stake In Monsanto (MON)

    Omnicare Inc. (OCR) Shares of OCR surged to reach a record high in after-hours trading Wednesday, following a report by Bloomberg indicating that drugstore operator CVS Health Corp. (CVS) is in advanced takeover talks with the company. OCR recently said that it expects full-year 2015 earnings (excluding special items) in the range of $4.08 to $4.16 per share, with revenue in the range of $6.5 billion to $6.7 billion OCR provides comprehensive pharmaceutical services to patients and providers across the United States. More about Omnicare Inc. (OCR) at www.omnicare.com ** Monsanto Company (MON) Billionaire Larry Robbins’ Glenview Capi

Stock Highlights

Heron Therapeutics (HRTX) Momentum on Top-Line Study Results; Is Rosetta Stone (RST) a Takeover Target?

29 May 2015 01:46 | Featured 1 (500x300), Stock Highlights

Heron Therapeutics, Inc. (HRTX) Shares of HRTX soared to reach a record high in extended-hours trading Thursday after the company reported positive, top-line results from its recently completed Phase 3 MAGIC study. According to HRTX, its 5-HT3 receptor antago ... | Read

Kevin Douglas Bets on EnteroMedics (ETRM); Popeyes (PLKI) and AMERCO (UHAL) Top Estimates

28 May 2015 02:32 | Featured 1 (500x300), Stock Highlights

EnteroMedics Inc. (ETRM) Kevin Douglas, an active securities and commodities investor, disclosed on Wednesday in a regulatory filing ( SC 13D ) with the Securities and Exchange Commission (SEC) a 14.2% stake in ETRM (10,951,705 shares). ETRM reported last wee ... | Read

XBiotech (XBIT) Biotechnology-Cloning Anti-Ebola; RadiSys (RSYS) Inks 8-Figure Deal

27 May 2015 12:47 | Featured 1 (500x300), Stock Highlights

XBiotech Inc. (XBIT) Shares of XBIT surged more than 10% in after-hours trading Tuesday as the company reported that it has successfully isolated and cloned an anti-Ebola product candidate using its True Human antibody discovery platform True Human antibodies ... | Read

Business News

Viggo Productions Support Risk-Free Purchasing With A Lifetime Replacement Warranty On Products

29 May 2015 01:00 | Business News

(EMAILWIRE.COM, May 29, 2015 ) Simi Valley, CA -- Consumers looking for value for money on quality fitness equipment may be interested to learn more about Viggo Productions and their premier Viggopr ... | Read

  Customers Happiness With The Salsa Bowls Of Celebright Proves Their Satisfaction
  29 May 2015 01:00
   
  Manuka Oil Is Being Described As Incredible When It Comes To Treating Life-Long Acne Prone Skin
  29 May 2015 01:00
   

Health & Medical

Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d

04 Feb 2014 08:42 | Health & Medical, Stock Highlights

Studies Meet FDA and EMA Primary Endpoints Conference Call and Webcast Scheduled for 8:30 a.m. ET Today MORRISVILLE, N.C. Feb. 4, 2014 - (CRWE Press Release) - Furiex Pharmaceuticals, Inc. (NASDAQ: F ... | Read

  Luna announces sale of shape-sensing technology for medical applications
  22 Jan 2014 15:52
   
  Rosetta Genomics Announces Master Service Provider Agreement With a Major, Global Biopharmaceutical Company
  13 Jan 2014 12:21
   

Politics

Obama Speaks To Iranian President Hassan Rouhani in New York

27 Sep 2013 03:04 | Featured 1 (500x300), Politics

For the first time in over 30 years, the two heads of states of the United States and Iran have had direct communication. It was the first step in efforts to discuss negotiations regarding Iran's ... | Read

  Media Users On Politics
  26 Sep 2013 13:43
   
  Anthony Weiner, A Sore Loser
  11 Sep 2013 11:21
   

Press Releases

Quest Solution to Present at LD Micro Invitational Investor Conference

29 May 2015 01:38 | Press Releases

HENDERSON, NV / CRWEPRESSRELEASE / May 29, 2015 / Quest Solution, Inc, “The Company” (OTCMKTS:QUES), a leading provider in the technology, software, and mobile data collection systems busi ... | Read

  Endurance Gold Closes Private Placement Of $340,000 and Announces Results Of Annual General Meeting
  29 May 2015 13:37
   
  Hornby Bay Announces Resignation of Officer and Director
  29 May 2015 13:37
   

Recents News

Quest Solution to Present at LD Micro Invitational Investor Conference

May 29th, 2015

Endurance Gold Closes Private Placement Of $340,000 and Announces Results Of Annual General Meeting

May 29th, 2015

Hornby Bay Announces Resignation of Officer and Director

May 29th, 2015

Propanc Briefs Investors at the SeeThruEquity 4th Annual Investor Conference

May 29th, 2015

Wi2Wi Corporation Reports First Quarter Results

May 29th, 2015

Cadan Resources Announces the Appointment of Richelle Singson Michael to the Board of Directors

May 29th, 2015
  • CRWE Network

  •